Related Experiment Video
Updated: Aug 15, 2026

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
Published on: January 26, 2019
Global Measles and Rubella Laboratory Network, January 2004-June 2005
Abstract:
Measles continues to be a leading cause of childhood morbidity and mortality in developing countries and an outbreak threat in the majority of countries. In 2000, measles was considered the fifth leading cause of childhood mortality, and the World Health Organization (WHO) estimated that approximately 777,000 measles-associated deaths occurred worldwide. In 2001, WHO and the United Nations Children's Fund (UNICEF) developed a 5-year strategic plan, endorsed by the World Health Assembly in 2003, to reduce measles mortality by 50% by 2005 (relative to 1999 estimates) and to achieve and maintain interruption of indigenous measles transmission in large geographic areas with established measles elimination goals. This plan included strengthening routine vaccination coverage, providing a second opportunity for measles immunization to children, improving measles case management, and improving surveillance with laboratory confirmation of suspected measles cases. To date, four of six WHO regions have established measles elimination targets: the Americas Region (AMR) by 2000, the European Region (EUR) by 2010, the Eastern Mediterranean Region (EMR) by 2010, and the Western Pacific Region (WPR) by 2012. The remaining two WHO regions, the African (AFR) and South East Asian (SEAR) regions, are continuing work toward the measles mortality reduction goal. Likewise, to reduce the burden of disease from congenital rubella syndrome (CRS), currently estimated at 100,000 cases per year worldwide, several countries have developed or continue to develop rubella control programs, and AMR and EUR have established regional rubella elimination and CRS reduction goals, respectively. Because improved global surveillance is essential for monitoring progress toward mortality reduction and elimination of these diseases, WHO established the Measles and Rubella Laboratory Network (LabNet) in 2003 to promote case identification and confirmation. This report provides an update on the development of LabNet during January 2004-June 2005 and describes the geographic distribution of measles and rubella virus genotypes as of June 2005.
Insights
Measles and rubella control efforts are ongoing globally, with a focus on reducing childhood mortality and eliminating transmission. The Measles and Rubella Laboratory Network (LabNet) was established to improve surveillance and case confirmation.
Area of Science:
- Public Health
- Virology
- Epidemiology
Background:
- Measles remains a significant cause of childhood illness and death, particularly in developing nations, and poses an outbreak risk globally.
- In 2000, measles caused an estimated 777,000 deaths worldwide, highlighting the urgent need for control strategies.
Purpose of the Study:
- To provide an update on the development of the Measles and Rubella Laboratory Network (LabNet) from January 2004 to June 2005.
- To describe the geographic distribution of measles and rubella virus genotypes as of June 2005.
Main Methods:
- Strengthening routine vaccination coverage and providing second opportunities for measles immunization.
- Improving measles case management and enhancing surveillance with laboratory confirmation.
- Establishing the Measles and Rubella Laboratory Network (LabNet) to support global monitoring.
Main Results:
- Four WHO regions have set measles elimination targets, while others focus on mortality reduction.
- Regional goals for rubella elimination and congenital rubella syndrome (CRS) reduction are being pursued.
- LabNet development is crucial for monitoring progress in measles and rubella control.
Conclusions:
- Global collaboration and robust laboratory surveillance are essential for achieving measles and rubella control and elimination goals.
- The Measles and Rubella Laboratory Network (LabNet) plays a vital role in tracking viral genotypes and guiding public health interventions.

